Acreage Holdings Announces September 2019 Conference Attendance
Acreage Holdings, Inc. ("Acreage") (CSE: ACRG.U) (OTCQX: ACRGF) (FSE: 0VZ) today announced its management team will attend three institutional investor conferences, a leading cannabis industry conference and a summit aligned with United Nations Assembly Week in September of 2019.
Acreage Holdings Hires Steve Hardardt As Chief People Officer
Acreage Holdings, Inc. ("Acreage") (CSE: ACRG.U) (OTCQX: ACRGF) (FSE: 0ZV) today announced the hiring of Steve Hardardt as Executive Vice President, Chief People Officer and Administration (CPO). A human resources and operations executive with over 30 years of experience at such companies as Dow Jones, Inc., Frito-Lay, Inc., Monsanto, Inc., tw telecom and others, Mr. Hardardt will be responsible for leading Acreage's Human Resources team to ensure the integration and implementation of HR strategy and programs with Acreage's business objectives. He will report to Kevin Murphy, Chairman and CEO of Acreage.
Established Markets Take Note as the Cannabis Industry Maintains its Growth
The exponential growth of the cannabis industry has put it on track to once again report record spending on lobbying in the U.S. capital. As of mid-year 2019, expenses on persuading members of Congress have already reached USD 1.6 Million compared to 2018's full-year expense of USD 2.7 Million, according to MarketWatch. The lobbying efforts come after Congress released a series of bills that would affect already enacted legislation, such as the STATES Act. The movement by cannabis advocates is aimed towards protecting states that have already legalized the use of either medical or recreational cannabis. However, in the light of the growing industry, lawmakers have become worried that the industry is beginning to compete against, or even merge with, other large industries such as big tobacco, alcohol or the pharmaceutical markets. In particular, cannabis has already tapped into the pharmaceutical industry because many medical institutions and health officials believe that cannabis can be effectively used as a medicinal treatment to a variety of conditions. For instance, numerous clinical trials have concluded that cannabis can be effectively used to treat symptoms associated with cancer, arthritis, multiple sclerosis, and epilepsy. Moreover, multiple large pharmaceutical companies have even added cannabis-based operations to further propel the growth of the medical cannabis market. Nevertheless, the industry is currently hindered by the lack of political support. Many national governments are hesitant about entering into the cannabis industry because of the stereotypes revolving around the plant such as its psychoactive properties. Nonetheless, a handful of countries have already taken the step forward and legalized the use of medical cannabis. Now, as more countries continue to legalize the plant, the sweeping movement is thought to have the potential to influence additional countries to explore opportunities within the industry. According to data compiled by Verified Market Research, the global marijuana market was valued at USD 42.20 Billion in 2016. By 2025, the market is expected to reach USD 466.81 Billion while registering a CAGR of 35.3% from 2018 to 2025. Pasha Brands Ltd. (OTC: CRFTF) (CSE: CRFT), Innovative Industrial Properties, Inc. (NYSE: IIPR), Curaleaf Holdings, Inc. (OTC: CURLF) (CSE: CURA), Acreage Holdings Inc. (OTC: ACRGF) (CSE: ACRG.U), MariMed Inc. (OTC: MRMD)